Amgen (NQ: AMGN )
298.62
+0.12
(+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 14, 2024
Add to My Watchlist
Headline News about Amgen
![](https://cdn.benzinga.com/files/images/story/2022/11/30/hznp_logo_dark__fcacfa4bb26e9464cd35895ca9749d1f_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/711191/big-fish-eating-little-fish.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/medicine-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/30/iphone_14_pro_0.jpg?width=1200&height=800&fit=crop)
$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today
November 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/18/amgen_logo.jpg?width=1200&height=800&fit=crop)
Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth
November 18, 2022
Via Benzinga
What 7 Analyst Ratings Have To Say About Amgen
November 18, 2022
Via Benzinga
Analyst Ratings for Amgen
November 18, 2022
Via Benzinga
Where Amgen Stands With Analysts
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/30/hznp_logo_dark__fcacfa4bb26e9464cd35895ca9749d1f.png?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2019/02/Stock-HorizonPharma-01-company.jpg)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/november/recap/indexesnov23.jpg?sfvrsn=ac4dad06_2)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-Biotech-13-Adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2503.jpeg?width=1200&height=800&fit=crop)
Amgen Earnings Perspective: Return On Invested Capital
November 17, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/708412/dividend-bank-roll.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709655/doctor-holding-elderly-patients-hand.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/dividend-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2460.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21498.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/14/shutterstock_248898337.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/12/josh_gottheimer.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2018/11/Stock-BoardArrowUp-04-adobe.jpg)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/november/recap/indexesnov8.jpg?sfvrsn=3530ad06_2)
![](https://www.investors.com/wp-content/uploads/2018/05/stock-Amgen-03-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/07/logo_light__558d5ea8f3221643a8794dc1c53bb8f1.png?width=1200&height=800&fit=crop)
Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study
November 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/04/elon_musktwitter.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/04/amgen_autoinjector_with_amgevita_by_amgen_adalimumab-6391.jpg?width=1200&height=800&fit=crop)
Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth
November 04, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.